VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13 by Koichi Kokame, Masanori Matsumoto, Yoshihiro.

Slides:



Advertisements
Similar presentations
Target protein Additional file 3. SDS-PAGE showing the degree of purification of D1-26PtxtPL1-27 expressed in E. coli. PtxtPL1-27.
Advertisements

The distal carboxyl-terminal domains of ADAMTS13 are required for regulation of in vivo thrombus formation by Fumiaki Banno, Anil K. Chauhan, Koichi Kokame,
Activation of factor XI by products of prothrombin activation
Epitope mapping of ADAMTS13 autoantibodies in acquired thrombotic thrombocytopenic purpura by Christoph Klaus, Barbara Plaimauer, Jan-Dirk Studt, Friedrich.
Shielding the front-strand β3 of the von Willebrand factor A1 domain inhibits its binding to platelet glycoprotein Ibα by Arnaud Bonnefoy, Hiroshi Yamamoto,
Kirby R. Siemering, Ralph Golbik, Richard Sever, Jim Haseloff 
Effects of inflammatory cytokines on the release and cleavage of the endothelial cell–derived ultralarge von Willebrand factor multimers under flow by.
by Weiqiang Gao, Patricia J. Anderson, and J. Evan Sadler
BRCA1 Is Associated with a Human SWI/SNF-Related Complex
Characterization of an ADAMTS-5-mediated cleavage site in aggrecan in OSM- stimulated bovine cartilage  M. Durigova, M.Sc., P. Soucy, B.Sc., K. Fushimi,
Volume 69, Issue 1, Pages (January 2006)
Lipopolysaccharide Activates Caspase-1 (Interleukin-1–Converting Enzyme) in Cultured Monocytic and Endothelial Cells by Ralf R. Schumann, Claus Belka,
by Jing Huang, David G. Motto, David R. Bundle, and J. Evan Sadler
by Chong-Shan Shi, Joseph Tuscano, and John H. Kehrl
Sebastian D Fugmann, David G Schatz  Molecular Cell 
von Willebrand factor is a cofactor in complement regulation
Cloning, expression, and functional characterization of the von Willebrand factor–cleaving protease (ADAMTS13)‏ by Barbara Plaimauer, Klaus Zimmermann,
Human peptidoglycan recognition protein S is an effector of neutrophil-mediated innate immunity by Ju Hyun Cho, Iain P. Fraser, Koichi Fukase, Shoichi.
Autoinhibition of c-Abl
Kyu-Ho Park, Catherine Berrier, Boris Martinac, Alexandre Ghazi 
Kre1p, the Plasma Membrane Receptor for the Yeast K1 Viral Toxin
Diagnostic detection of Streptococcus pneumoniae PpmA in urine
H-NS2 protein interacts with Lon and H-NS protein in vitro.
Sherif Abou Elela, Haller Igel, Manuel Ares  Cell 
Volume 3, Issue 1, Pages (January 1999)
Gene expression and immunologic consequence of SPAN-Xb in myeloma and other hematologic malignancies by Zhiqing Wang, Yana Zhang, Haichao Liu, Emanuela.
Volume 12, Issue 4, Pages (October 2003)
Volume 6, Issue 5, Pages (September 2013)
Volume 1, Issue 5, Pages (April 1998)
Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor by Anne F. Riddell,
Hsp104, Hsp70, and Hsp40  John R Glover, Susan Lindquist  Cell 
TEV protease elution from cellulose is specific and provides highly purified target protein. TEV protease elution from cellulose is specific and provides.
Volume 15, Issue 1, Pages (July 2001)
Volume 135, Issue 2, Pages e1 (August 2008)
Enzyme-linked immunosorbent assay measurements of antimüllerian hormone (AMH) in human blood are a composite of the uncleaved and bioactive cleaved forms.
A novel calcium-binding site of von Willebrand factor A2 domain regulates its cleavage by ADAMTS13 by Minyun Zhou, Xianchi Dong, Carsten Baldauf, Hua Chen,
(a) (b) FhGALE M U I S W1 W2 E1 E2 E3 M - +
The Transmembrane Kinase Ire1p Is a Site-Specific Endonuclease That Initiates mRNA Splicing in the Unfolded Protein Response  Carmela Sidrauski, Peter.
Volume 91, Issue 2, Pages (October 1997)
M.Brandon Parrott, Michael A. Barry  Molecular Therapy 
Role of calcium in regulating the intra- and extracellular cleavage of von Willebrand factor by the protease ADAMTS13 by Shobhit Gogia, Anju Kelkar, Changjie.
Distinct Roles for CTD Ser-2 and Ser-5 Phosphorylation in the Recruitment and Allosteric Activation of Mammalian mRNA Capping Enzyme  C.Kiong Ho, Stewart.
More Than One Glycan Is Needed for ER Glucosidase II to Allow Entry of Glycoproteins into the Calnexin/Calreticulin Cycle  Paola Deprez, Matthias Gautschi,
Volume 91, Issue 4, Pages (November 1997)
Homo-Oligomerization of Human Corneodesmosin Is Mediated by Its N-Terminal Glycine Loop Domain  Cécile Caubet, Nathalie Jonca, Frédéric Lopez, Jean-Pierre.
Autoantibodies in a Subgroup of Patients with Linear IgA Disease React with the NC16A Domain of BP1801  Detlef Zillikens, Karin Herzele, Matthias Georgi,
Class C Vps Protein Complex Regulates Vacuolar SNARE Pairing and Is Required for Vesicle Docking/Fusion  Trey K. Sato, Peter Rehling, Michael R. Peterson,
Volume 96, Issue 5, Pages (March 1999)
Volume 17, Issue 1, Pages (January 2010)
A Branched Pathway Governing the Activation of a Developmental Transcription Factor by Regulated Intramembrane Proteolysis  Nathalie Campo, David Z. Rudner 
p53 Protein Exhibits 3′-to-5′ Exonuclease Activity
Targeted Proteomic Study of the Cyclin-Cdk Module
Coding Joint Formation in a Cell-Free V(D)J Recombination System
The DnaK Chaperone System Facilitates 30S Ribosomal Subunit Assembly
Volume 3, Issue 2, Pages (August 2002)
Frida E. Kleiman, James L. Manley  Cell 
Volume 96, Issue 3, Pages (February 1999)
Volume 11, Issue 24, Pages (December 2001)
Localization of the Iff8 extended protein.
Volume 31, Issue 6, Pages (September 2008)
Involvement of PIAS1 in the Sumoylation of Tumor Suppressor p53
Volume 11, Issue 3, Pages (March 2003)
Human Pre-mRNA Cleavage Factor Im Is Related to Spliceosomal SR Proteins and Can Be Reconstituted In Vitro from Recombinant Subunits  Ursula Rüegsegger,
Interaction of NF-L with C1 cassette-containing NR1 splice variants.
Volume 14, Issue 2, Pages (April 2004)
Volume 9, Issue 1, Pages (January 2002)
A Minimal RNA Polymerase III Transcription System from Human Cells Reveals Positive and Negative Regulatory Roles for CK2  Ping Hu, Si Wu, Nouria Hernandez 
Minoru Funakoshi, Robert J. Tomko, Hideki Kobayashi, Mark Hochstrasser 
The recombinant 4D5MOCB-ETA immunotoxin.
Volume 3, Issue 1, Pages (January 1999)
Presentation transcript:

VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13 by Koichi Kokame, Masanori Matsumoto, Yoshihiro Fujimura, and Toshiyuki Miyata Blood Volume 103(2):607-612 January 15, 2004 ©2004 by American Society of Hematology

Structures of VWF and fusion proteins for ADAMTS-13 substrate. Structures of VWF and fusion proteins for ADAMTS-13 substrate. The domain structure of human preproVWF is shown above the structures of recombinant fusion proteins designed in the present study. Amino acid residues of preproVWF are numbered from the initiating Met codon. The locations of 5 kinds of structural domains (A, B, C, D, and CK) are indicated. The mature VWF secreted from cells consists of 2050 residues (S764-K2813) from the D′ domain to the C-terminal CK domain. ADAMTS-13 cleaves the Y1605-M1606 peptidyl bond in the A2 domain (D1498-L1664). We made 5 different recombinant proteins flanked with GST- and H-tags: GST-D1459R1668-H (I), GST-E1554R1668-H (II), GST-D1587R1668-H (III), GST-D1596R1668-H (IV), and GST-D1596R1659-H (V). Koichi Kokame et al. Blood 2004;103:607-612 ©2004 by American Society of Hematology

Preparation of bacterial recombinant proteins. Preparation of bacterial recombinant proteins. (A) Expression. Arrowheads indicate 5 recombinant proteins expressed in E coli after IPTG induction: GST-D1459R1668-H (I), GST-E1554R1668-H (II), GST-D1587R1668-H (III), GST-D1596R1668-H (IV), and GST-D1596R1659-H (V). Gels after SDS-PAGE were stained with GelCode Blue (Pierce, Rockford, IL). The sizes of the protein standards are indicated at the left. (B) Fractionation. Recombinant proteins I and II were collected in pellet fractions (P) after centrifugation, whereas III, IV, and V were in soluble fractions (S). (C) Purification. All the recombinant proteins were purified by 2 sequential column-chromatography procedures, nickel-ion chelating chromatography and glutathione-affinity chromatography. The representative pattern of GST-D1596R1668-H is shown. S indicates soluble fraction of bacterial lysate; F1, flow-through of nickel-ion column; W1, wash; E1, eluate; F2, flow-through of glutathione column; W2, wash; and E2, eluate. Koichi Kokame et al. Blood 2004;103:607-612 ©2004 by American Society of Hematology

Cleavage of recombinant proteins by normal plasma. Cleavage of recombinant proteins by normal plasma. The recombinant substrates (I-V) were incubated with normal plasma at 37°C for 0 hours (lanes 1, 3, 5, 7, and 9) or 1 hour (lanes 2, 4, 6, 8, and 10). Both substrates and products were detected by Western blot using anti-GST. The product bands including N-terminal GST-tag are indicated by arrowheads. Substrates III and IV were cleaved more efficiently than I and II, and substrate V was not cleaved. The arrowed bands observed in all lanes are nonspecific signals derived from plasma albumin. The bands with asterisks, probably contaminating degradation products, are reproducible background signals. Koichi Kokame et al. Blood 2004;103:607-612 ©2004 by American Society of Hematology

Effect of urea and ion strength on cleavage. Effect of urea and ion strength on cleavage. GST-VWF73-H was incubated with normal plasma for the indicated time in reaction buffer (5 mM Tris-HCl, 10 mM BaCl2, pH 8.0) (lanes 1-3) or in the same buffer supplemented with either 1.5 M urea (lanes 4-6) or 150 mM NaCl (lanes 7-9). The substrate and product bands are shown by an arrow and an arrowhead, respectively. Koichi Kokame et al. Blood 2004;103:607-612 ©2004 by American Society of Hematology

Cleavage of GST-VWF73-H by patients' plasma. Cleavage of GST-VWF73-H by patients' plasma. GST-VWF73-H was incubated with serially diluted normal plasma (0%-100%) or with plasma from patients with USS, ticlopidine-associated TTP (Tc-TTP), idiopathic TTP, and HUS. The band intensities of reaction products were measured by chemiluminescence on Western blot, and the relative activities of patients' plasma (%, shown by italic numbers) to normal plasma were calculated from nonlinear regression by serially diluted normal plasma. USS patients 1 to 3 correspond to ST-III-4, SY-III-1, and KI-III-2 by previous report.2 Tc-TTP patients 1 and 2 were reported by Sugio et al35 and Orimo et al,36 respectively. The idiopathic TTP patients 1 to 9 correspond to the case numbers 1-3, 5, 6, 11-13, and 17, and HUS patients 1 to 4 correspond to the case numbers 2, 4, 6, and 9 in the previous report.37 Koichi Kokame et al. Blood 2004;103:607-612 ©2004 by American Society of Hematology

Inhibitory activity of plasma from patients. Inhibitory activity of plasma from patients. Normal plasma was preincubated with equal volumes of heat-inactivated plasma from patients with USS (lanes 2-4), Tc-associated TTP (lanes 5-6), and idiopathic TTP (lane 7). Then, cleavage of GST-VWF73-H was compared with normal plasma without preincubation (lane 1). Plasma from patients with acquired TTP but not with USS inhibited substrate cleavage. Koichi Kokame et al. Blood 2004;103:607-612 ©2004 by American Society of Hematology